M-Tor Inhibitors in the Treatment of Advanced Renal Cell Carcinoma

Wspolczesna Onkologia- Poland

doi 10.5114/wo.2011.26432

Full Text

Abstract

Available in

Date

Authors

Publisher

Termedia Sp. z.o.o.

Related search

Comparison of Calcineurin Inhibitors With M-Tor Inhibitors in Renal Transplant Patients

Akdeniz Medical Journal
2015English

Nivolumab in the Treatment of Advanced Renal Cell Carcinoma

Oncology in Clinical Practice
Oncology
2019English

Profile of Temsirolimus in the Treatment of Advanced Renal Cell Carcinoma

OncoTargets and Therapy
OncologyPharmacology
2010English

Clinical Experience With Temsirolimus in the Treatment of Advanced Renal Cell Carcinoma

Therapeutic Advances in Urology
Urology
2015English

The Bevacizumab Experience in Advanced Renal Cell Carcinoma

OncoTargets and Therapy
OncologyPharmacology
2010English

Tivozanib in the Treatment of Renal Cell Carcinoma

Biologics: Targets and Therapy
OncologyImmunologyGastroenterologyPharmacologyRheumatologyAllergy
2013English

Management of Locally Advanced Renal Cell Carcinoma

Cancer Control
MedicineOncologyHematology
2006English

Concomitant Oral Tyrosine Kinase Inhibitors and Bisphosphonates in Advanced Renal Cell Carcinoma With Bone Metastases

British Journal of Cancer
Cancer ResearchOncology
2012English

Angiotensin Inhibitors as Treatment of Sunitinib/Pazopanib-Induced Hypertension in Metastatic Renal Cell Carcinoma

Clinical Genitourinary Cancer
OncologyUrology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy